Zimbabwe has turned down a major US healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years because of Washington's insistence on confidential biological samples.
The decision became public after a official document from December was leaked, revealing that Head of State Emmerson Mnangagwa believed the agreement was "unbalanced".
A government spokesperson later stated that the US was seeking health data for research and commercial gain while was unwilling to share the resulting advantages from any future vaccines.
"We are forced to start the challenging and unfortunate task of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had provided over $1.9bn as health assistance to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has urged continued talks to reach a deal acceptable to all parties so the nation's critical HIV programme can continue.
Wider Background
Zimbabwe's decision follows a comparable situation in neighbouring Kenya, where a court suspended a related deal with the US after legal challenges were filed about the safety of Kenyans' health data.
After returning to office recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
The agency had overseen aid for the US government, but Trump argued its spending was "inefficient" and his administration was seeking direct bilateral deals to enhance openness and accountability.
According to statements, Sixteen African countries have to date agreed to these new health pacts, representing more than $18.3bn in new funding.
Specifics of the Rejected Deal
The money for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We believe this collaboration might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on HIV treatment via American-funded programmes," the Ambassador added.
However, official spokesman Nick Mangwana maintained the arrangement was "asymmetrical".
"Our nation was requested to share its biological resources and data indefinitely, with no corresponding promise of access to any scientific breakthroughs – like new medicines or tests – that could result from that provided information," he stated.
"Effectively, our country would provide the raw materials for scientific discovery with no assurance that the end products would be accessible to our population should a new health crisis arise."
Sovereignty and Global Health
He also noted that the American exit from the global health body and its pursuit of bilateral health agreements were upending structures already established via the global organization.
Mangwana cited its Pandemic Benefit-Sharing framework created to manage potential global health emergencies.
"This framework is intended to guarantee that when a nation contributes its data, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised solely by those with the resources to create them."
Zimbabwe's reservations over the US deal "should not be misconstrued as opposition to America," he added.
"We are open to continued discussions with our US partners on how subsequent co-operation might be arranged in a way that respects the independence and dignity of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the official position, but recommended that negotiations should continue considering much of the nation's Aids initiatives relied on international support.
"Where technical issues arise, such as those relating to data governance or agreement terms, these can frequently be resolved through detailed discussion and negotiated safeguards," it added.
This impasse highlights the complex tensions between accepting much-needed foreign assistance and safeguarding local interests in an ever more interconnected world.